Ares Financial Consulting’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$29.6K Hold
408
– – 0.02% 329
2026
Q2
$28.8K Sell
408
-60
-13% -$3.24K 0.02% 339
2026
Q1
$25K Buy
468
+360
+333% +$21.6K 0.02% 345
2025
Q4
$6.35K Buy
+108
New +$6.56K 0.01% 435

Other funds holding TECH

Ares Financial Consulting's TECH Position: Q3 2026 in Review

Ares Financial Consulting held its Bio-Techne (TECH) position steady in Q3 2026 at 408 shares worth $29.6K. The position accounts for 0.02% of the portfolio, ranked #329.

Ares Financial Consulting first reported a position in TECH in Q4 2025 and has held it in 4 quarters since. 581 funds tracked by Wall St. Rank hold TECH as of Q3 2026.

  • Ares Financial Consulting held 408 shares of Bio-Techne worth $29.6K as of Q3 2026.
  • Ares Financial Consulting left its Bio-Techne share count unchanged in Q3 2026.
  • Bio-Techne made up 0.02% of Ares Financial Consulting's portfolio in Q3 2026, its #329 holding.
  • Ares Financial Consulting first reported a position in Bio-Techne in Q4 2025 and has held it in 4 quarters since.
  • 581 funds tracked by Wall St. Rank held Bio-Techne as of Q3 2026.

Based on Ares Financial Consulting's 13F filing for Q3 2026, filed 19 Oct 2026.